Rivaroxaban as a Protector of Oxidative Stress-Induced Vascular Endothelial Glycocalyx Damage via the IQGAP1/PAR1-2/PI3K/Akt Pathway
Journal of Vascular Research · 2024
DOI: 10.1159/000542419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Research, 2024. Verfasst von Lisa Kitasato und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan. Hauptthemen laut MEDLINE: Oxidative Stress, Glycocalyx, Proto-Oncogene Proteins c-akt, Human Umbilical Vein Endothelial Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The vascular endothelial glycocalyx, crucial for blood vessel integrity and homeostasis, is vulnerable to oxidative stress, leading to endothelial dysfunction, which strongly correlates with cardiovascular disease (CVD). This study investigates the protective effects of rivaroxaban, a factor X inhibitor, on the glycocalyx under oxidative stress condition.
Methods
We examined the impact of rivaroxaban on human umbilical vein endothelial cells exposed to acute and chronic H2O2-induced oxidative stress.
Results
Rivaroxaban dose-dependently suppressed syndecan-1, a key component of the glycocalyx, shedding from cell surface, and enhanced protease-activated receptor (PAR)1-PAR2/phosphatidylinositol-3-kinase (PI3K)-dependent cell viability after acute induction of H2O2. This protective effect was linked to the translocation of IQGAP1, a scaffold protein that modulates the actin cytoskeleton, to the perinucleus from the cell membrane. Under chronic H2O2 treatments, rivaroxaban improves cell viability accompanied by an increase in hyaluronidase activities, aiding the turnover and remodeling of hyaluronic acid within the glycocalyx.
Conclusion
We identify that rivaroxaban protects against oxidative stress-induced endothelial glycocalyx damage and cell viability through IQGAP1/PAR1-2/PI3K/Akt pathway, offering a potential to be a therapeutic target for CVD prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
- Department of Rehabilitation, Kitasato University School of Allied Health Sciences, Sagamihara, Japan.
- Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.
- Department of Kitasato Clinical Research Center, Kitasato University School of Medicine, Sagamihara, Japan.
- Department of Regulation Biochemistry, Kitasato University School of Allied Health Sciences, Sagamihara, Japan.
- Department of Emergency Medicine, School of Medicine, Yokohama City University, Yokohama, Japan.
Zitieren
APA
Kitasato, L., Yamaoka-Tojo, M., Iwaya, T., Murayama, Y., Ikeda, Y., Hashikata, T., Oikawa, J., Suzuki, M., Misawa, N., Kawashima, R., Ogawa, F., & Ako, J. (2024). Rivaroxaban as a Protector of Oxidative Stress-Induced Vascular Endothelial Glycocalyx Damage via the IQGAP1/PAR1-2/PI3K/Akt Pathway. Journal of Vascular Research. https://doi.org/10.1159/000542419
Vancouver
Kitasato L, Yamaoka-Tojo M, Iwaya T, Murayama Y, Ikeda Y, Hashikata T, et al. Rivaroxaban as a Protector of Oxidative Stress-Induced Vascular Endothelial Glycocalyx Damage via the IQGAP1/PAR1-2/PI3K/Akt Pathway. Journal of Vascular Research. 2024. doi:10.1159/000542419
BibTeX
@article{Kitasato2024,
author = {Kitasato, Lisa and Yamaoka-Tojo, Minako and Iwaya, Toshiyuki and Murayama, Yusuke and Ikeda, Yuki and Hashikata, Takehiro and Oikawa, Jun and Suzuki, Machika and Misawa, Nonoka and Kawashima, Rei and Ogawa, Fumihiro and Ako, Junya},
title = {Rivaroxaban as a Protector of Oxidative Stress-Induced Vascular Endothelial Glycocalyx Damage via the IQGAP1/PAR1-2/PI3K/Akt Pathway},
journal = {Journal of Vascular Research},
year = {2024},
doi = {10.1159/000542419}
}
EUVIMED